Leerink Partners made a slight adjustment to the price target of Inspire Medical Systems (NYSE:INSP), raising it from $193.00 to $194.00, while keeping a Market Perform rating on the stock. According ...

Inspire (INSP) delivered earnings and revenue surprises of 55.41% and 0.04%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Inspire expects full-year earnings to be $2.10 to $2.20 per share, with revenue in the range of $940 million to $955 million. This story was generated by Automated Insights ( ...